Rain Oncology Inc. Proceeds from Issuance Initial Public Offering
Rain Oncology Inc. reported Proceeds from Issuance Initial Public Offering of $133.37 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2023-03-09
- Rain Oncology Inc. proceeds from issuance initial public offering for the quarter ending 2021-12-31 was $11.87M.
- Rain Oncology Inc. proceeds from issuance initial public offering for the quarter ending 2021-09-30 was $0.00.
- Rain Oncology Inc. proceeds from issuance initial public offering for the quarter ending 2021-06-30 was $121.50M.
- Rain Oncology Inc. proceeds from issuance initial public offering for fiscal 2021 was $133.37M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2021-12-31 | $11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $11.87M derived: sum of 2 quarters · filed 2023-03-09 | $133.37M derived: sum of 3 quarters · filed 2023-03-09 | $133.37M 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $121.50M derived: sum of 2 quarters · filed 2022-11-10 | $121.49M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $121.50M 10-Q · filed 2021-08-10 | $121.49M 10-Q · filed 2022-08-04 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |